APEX SRL
6.3 FTEThe score of APEX shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +37 % Total assets +32 % Headcount (avg FTE) +37 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
APEX's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 09 Dec 2025
- Year ended 30 Jun 2024filed on 11 Dec 2024
- Year ended 30 Jun 2023filed on 30 Jan 2024
- Year ended 30 Jun 2022filed on 31 Jan 2023
- Year ended 30 Jun 2021filed on 31 Jan 2022
APEX's financial analysis
- Solvency97.9%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of APEX
APEX's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0871.977.342
- VAT number
- BE0871977342
- Peppol
- Registered · 0208:0871977342 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Feb 2005
- Registered office
- 1420 Braine-l'Alleud
- Size
- Micro · 6.3 FTE
- Latest accounts
- 2025 · filed on 09 Dec 2025
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
APEX (SRL) has been based in Braine-l'Alleud since 2005, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 127,585 € and equity of €5.14m; its revenue is not published. With 6.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 97.9%, above the median of its sector (43.9%).
Companies similar to APEX
Companies in the same business, of comparable size and area, outside its group.
- Derco - Anciens Etablissements Jos. Derycke Wholesale of pharmaceutical and medical goods Ittre · balance sheet €3.71m
- Concept Dental AL Installation of industrial machinery and equipment Remicourt · balance sheet €1.10m
- Varian Medical Systems Belgium Manufacture of medical and dental instruments and supplies Dilbeek · balance sheet €20.0m
- King Belgium Wholesale of pharmaceutical and medical goods Rixensart · balance sheet €72.2m
- EKI'P Dental Wholesale of pharmaceutical and medical goods Wavre · balance sheet €5.78m
- Gynetics Medical Products Wholesale of pharmaceutical and medical goods Lommel · balance sheet €5.34m
- Labconsult Wholesale of pharmaceutical and medical goods Schaerbeek · balance sheet €3.55m
- XMED iQ France BeNeLux Wholesale of pharmaceutical and medical goods Brussels · balance sheet 653,917 €
Frequently asked questions about APEX
What is the revenue of APEX?
APEX files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of APEX?
In Belgium, the VAT number is the company number prefixed with BE: BE0871977342 for APEX, if the company is VAT-registered. Its company number (CBE) is 0871.977.342.
Where is the registered office of APEX?
According to the CBE register, the registered office of APEX is in 1420 Braine-l'Alleud.
What is the equity of APEX?
At the close of the 2025 financial year, the equity of APEX amounts to 5,137,280 €, a solvency of 97.9% of total assets.
How many people work at APEX?
6.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages APEX?
The register lists 5 active mandates at APEX. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of APEX
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →